Citadel Advisors’s Walgreens Boots Alliance WBA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-5,696,600
Closed -$65.4M 14262
2025
Q2
$65.4M Buy
5,696,600
+2,155,100
+61% +$24M 0.01% 1031
2025
Q1
$39.6M Buy
3,541,500
+1,054,300
+42% +$11.4M 0.01% 1361
2024
Q4
$23.2M Sell
2,487,200
-1,933,500
-44% -$18M ﹤0.01% 2020
2024
Q3
$39.6M Sell
4,420,700
-1,166,300
-21% -$12M 0.01% 1425
2024
Q2
$67.6M Buy
5,587,000
+932,600
+20% +$15.8M 0.01% 922
2024
Q1
$101M Buy
4,654,400
+2,274,200
+96% +$50.5M 0.02% 689
2023
Q4
$62.1M Buy
2,380,200
+112,700
+5% +$2.52M 0.01% 1015
2023
Q3
$50.4M Sell
2,267,500
-669,100
-23% -$17.8M 0.01% 1071
2023
Q2
$83.7M Buy
2,936,600
+578,200
+25% +$18.8M 0.02% 721
2023
Q1
$81.6M Sell
2,358,400
-577,800
-20% -$20.5M 0.02% 734
2022
Q4
$110M Buy
2,936,200
+249,400
+9% +$9.38M 0.03% 598
2022
Q3
$84.4M Sell
2,686,800
-147,000
-5% -$5.45M 0.02% 698
2022
Q2
$107M Buy
2,833,800
+168,600
+6% +$7.25M 0.03% 539
2022
Q1
$119M Buy
2,665,200
+765,600
+40% +$37.7M 0.02% 578
2021
Q4
$99.1M Buy
1,899,600
+15,700
+0.8% +$760K 0.02% 663
2021
Q3
$88.6M Buy
1,883,900
+1,060,900
+129% +$51.2M 0.02% 726
2021
Q2
$43.3M Sell
823,000
-646,400
-44% -$34.8M 0.01% 1256
2021
Q1
$80.7M Buy
1,469,400
+166,700
+13% +$8.24M 0.02% 701
2020
Q4
$52M Buy
1,302,700
+76,000
+6% +$2.94M 0.01% 924
2020
Q3
$44.1M Buy
1,226,700
+732,300
+148% +$28.6M 0.01% 953
2020
Q2
$21M Sell
494,400
-39,200
-7% -$1.66M 0.01% 1468
2020
Q1
$24.4M Sell
533,600
-193,400
-27% -$9.82M 0.01% 1079
2019
Q4
$42.9M Buy
727,000
+99,400
+16% +$5.73M 0.02% 870
2019
Q3
$34.7M Buy
627,600
+74,700
+14% +$4M 0.02% 1008
2019
Q2
$30.2M Sell
552,900
-173,500
-24% -$9.22M 0.01% 1067
2019
Q1
$46M Buy
726,400
+11,300
+2% +$772K 0.02% 733
2018
Q4
$48.9M Sell
715,100
-105,100
-13% -$8.15M 0.03% 632
2018
Q3
$59.8M Sell
820,200
-104,100
-11% -$7.07M 0.03% 654
2018
Q2
$55.5M Buy
924,300
+165,300
+22% +$10.6M 0.03% 640
2018
Q1
$49.7M Sell
759,000
-11,300
-1% -$807K 0.03% 608
2017
Q4
$55.9M Buy
770,300
+226,500
+42% +$16M 0.03% 563
2017
Q3
$42M Buy
543,800
+26,600
+5% +$2.13M 0.03% 640
2017
Q2
$40.5M Buy
517,200
+176,600
+52% +$14.5M 0.03% 598
2017
Q1
$28.3M Sell
340,600
-285,400
-46% -$23.9M 0.03% 748
2016
Q4
$51.8M Buy
626,000
+211,000
+51% +$17.4M 0.05% 371
2016
Q3
$33.5M Buy
415,000
+105,300
+34% +$8.59M 0.03% 583
2016
Q2
$25.8M Sell
309,700
-43,100
-12% -$3.48M 0.03% 625
2016
Q1
$29.7M Sell
352,800
-26,600
-7% -$2.12M 0.04% 533
2015
Q4
$32.3M Sell
379,400
-101,500
-21% -$8.62M 0.04% 578
2015
Q3
$40M Buy
480,900
+101,300
+27% +$9.16M 0.04% 533
2015
Q2
$32.1M Sell
379,600
-22,100
-6% -$1.91M 0.03% 715
2015
Q1
$34M Sell
401,700
-127,600
-24% -$10.2M 0.03% 674
2014
Q4
$40.3M Sell
529,300
-317,300
-37% -$21.2M 0.04% 563
2014
Q3
$50.2M Buy
846,600
+391,900
+86% +$25.7M 0.05% 410
2014
Q2
$33.7M Buy
454,700
+99,600
+28% +$6.96M 0.04% 541
2014
Q1
$23.4M Sell
355,100
-65,900
-16% -$4.14M 0.03% 742
2013
Q4
$24.2M Sell
421,000
-291,100
-41% -$16.9M 0.03% 696
2013
Q3
$38.3M Buy
712,100
+184,800
+35% +$9.29M 0.06% 405
2013
Q2
$23.3M Buy
+527,300
New +$25.7M 0.04% 579

Other funds holding WBA

Citadel Advisors's WBA Position: Q3 2025 in Review

Citadel Advisors sold out of Walgreens Boots Alliance (WBA) in Q3 2025, closing a stake of 5,571,340 shares — an estimated $64M sold.

Citadel Advisors first reported a position in WBA in Q2 2013 and held it in 49 quarters. The position peaked at $257M in Q2 2015. 9 funds tracked by Wall St. Rank hold WBA as of Q3 2025.

  • Citadel Advisors reported no remaining Walgreens Boots Alliance position as of Q3 2025 after selling out during the quarter.
  • Citadel Advisors sold 5,571,340 Walgreens Boots Alliance shares in Q3 2025, an estimated $64M.
  • Citadel Advisors first reported a position in Walgreens Boots Alliance in Q2 2013 and held it in 49 quarters.
  • Citadel Advisors's Walgreens Boots Alliance position peaked at $257M in Q2 2015.
  • 9 funds tracked by Wall St. Rank held Walgreens Boots Alliance as of Q3 2025.

Based on Citadel Advisors's 13F filing for Q3 2025, filed 14 Nov 2025.